Long-term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy

Overview

Journal J Vet Intern Med

Specialties General Medicine
Veterinary Medicine

Date 2016 Mar 4

PMID 26936799

Citations 13

Authors

A C Vollmar

P R Fox

Affiliations

Soon will be listed here.

Abstract

Background: Dilated cardiomyopathy (DCM) is a common cause of morbidity and mortality in the Irish Wolfhound (IW). However, the benefit of medical treatment in IW dogs with preclinical DCM, atrial fibrillation (AF), or both has not been demonstrated.

Objectives: Compare the time to develop congestive heart failure (CHF) or sudden death in IW dogs with preclinical DCM, AF, or both receiving monotherapy with pimobendan, methyldigoxin, or benazepril hydrochloride.

Animals: Seventy-five client-owned IW dogs.

Methods: Irish Wolfhound dogs were prospectively randomized to receive pimobendan (Vetmedin®), benazepril HCl (Fortekor®), or methyldigoxin (Lanitop®) monotherapy in a 1:1:1 ratio in a blinded clinical trial. The prospectively defined composite primary endpoint was onset of CHF or sudden death. To assure stringent evaluation of treatment effect, data from dogs complying with the study protocol were analyzed.

Results: Sixty-six IW fulfilling the study protocol included 39 males, 27 females; median (interquartile range) age, 4.0 years (3.0-5.0 years) and weight, 70.0 kg (63.0-75.0 kg). Primary endpoint was reached in 5 of 23 (21.7%) IW receiving pimobendan, 11 of 22 (50.0%) receiving benazepril HCl, and 9 of 21 (42.9%) receiving methyldigoxin. Median time to primary endpoint was significantly longer for pimobendan (1,991 days; 65.4 months) compared to methyldigoxin (1,263 days; 41.5 months; P = .031) or benazepril HCl-(997 days; 32.8 months; P = .008) treated dogs.

Conclusions And Clinical Importance: In IW dogs with preclinical DCM, AF or both, pimobendan monotherapy significantly prolonged time to onset of CHF or sudden death than did monotherapy with benazepril HCl or methyldigoxin.

Citing Articles

Basic triage in dogs and cats: Part I.

Thomovsky E, Ilie L Can Vet J. 2024; 65(2):162-172.

PMID: 38304479 PMC: 10783570.

Genetic Basis of Dilated Cardiomyopathy in Dogs and Its Potential as a Bidirectional Model.

Gaar-Humphreys K, Spanjersberg T, Santarelli G, Grinwis G, Szatmari V, Roelen B Animals (Basel). 2022; 12(13).

PMID: 35804579 PMC: 9265105. DOI: 10.3390/ani12131679.

Prevalence of sudden cardiac death in dogs with atrial fibrillation.

Borgeat K, Pack M, Harris J, Laver A, Seo J, Belachsen O J Vet Intern Med. 2021; 35(6):2588-2595.

PMID: 34750853 PMC: 8692199. DOI: 10.1111/jvim.16297.

Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.

Oldach M, Ueda Y, Ontiveros E, Fousse S, Visser L, Stern J BMC Vet Res. 2021; 17(1):89.

PMID: 33622315 PMC: 7903657. DOI: 10.1186/s12917-021-02799-9.

Echocardiographic and electrocardiographic evaluation of North American Irish Wolfhounds.

Tyrrell Jr W, Abbott J, Rosenthal S, Dentino M, Abrams F J Vet Intern Med. 2020; 34(2):581-590.

PMID: 32112595 PMC: 7096642. DOI: 10.1111/jvim.15709.

References

Boswood A . Current use of pimobendan in canine patients with heart disease. Vet Clin North Am Small Anim Pract. 2010; 40(4):571-80. DOI: 10.1016/j.cvsm.2010.04.003. View

Atkins C, Keene B, Brown W, Coats J, Crawford M, DeFrancesco T . Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J Am Vet Med Assoc. 2007; 231(7):1061-9. DOI: 10.2460/javma.231.7.1061. View

Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Haggstrom J . Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med. 2009; 23(6):1142-50. DOI: 10.1111/j.1939-1676.2009.0392.x. View

Borgarelli M, Tarducci A, Tidholm A, Haggstrom J . Canine idiopathic dilated cardiomyopathy. Part II: pathophysiology and therapy. Vet J. 2001; 162(3):182-95. DOI: 10.1053/tvjl.2001.0616. View

Brownlie S . An electrocardiographic survey of cardiac rhythm in Irish wolfhounds. Vet Rec. 1991; 129(21):470-1. DOI: 10.1136/vr.129.21.470. View

Watson A, Church D . Preferences of veterinarians for drugs to treat heart disease in dogs and cats. Aust Vet J. 1995; 72(11):401-3. DOI: 10.1111/j.1751-0813.1995.tb06187.x. View

Haggstrom J, Lord P, Hoglund K, Ljungvall I, Jons O, Kvart C . Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure. J Vet Intern Med. 2013; 27(6):1452-62. DOI: 10.1111/jvim.12217. View

. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol. 2008; 1(1):7-18. DOI: 10.1016/S1760-2734(06)70025-X. View

Hunt S, Abraham W, Chin M, Feldman A, Francis G, Ganiats T . 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.... J Am Coll Cardiol. 2009; 53(15):e1-e90. DOI: 10.1016/j.jacc.2008.11.013. View

10.

Ouyang A, Lv Y, Zhong H, Wen J, Wei X, Peng H . Meta-analysis of digoxin use and risk of mortality in patients with atrial fibrillation. Am J Cardiol. 2015; 115(7):901-6. DOI: 10.1016/j.amjcard.2015.01.013. View

11.

Sabbah H, Shimoyama H, Kono T, Gupta R, Sharov V, Scicli G . Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation. 1994; 89(6):2852-9. DOI: 10.1161/01.cir.89.6.2852. View

12.

Kvart C, Haggstrom J, Pedersen H, Hansson K, Eriksson A, Jarvinen A . Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med. 2002; 16(1):80-8. View

13.

Honerjager P, Heiss A, Schafer-Korting M, Schonsteiner G, Reiter M . UD-CG 115--a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle. Naunyn Schmiedebergs Arch Pharmacol. 1984; 325(3):259-69. DOI: 10.1007/BF00495953. View

14.

Vollmar A . The prevalence of cardiomyopathy in the Irish wolfhound: a clinical study of 500 dogs. J Am Anim Hosp Assoc. 2000; 36(2):125-32. DOI: 10.5326/15473317-36-2-125. View

15.

Koch J, Pedersen H, Jensen A, Flagstad A, Poulsen K . Activation of the renin-angiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy. Res Vet Sci. 1995; 59(2):172-5. DOI: 10.1016/0034-5288(95)90055-1. View

16.

Summerfield N, Boswood A, OGrady M, Gordon S, Dukes-McEwan J, Oyama M . Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study). J Vet Intern Med. 2012; 26(6):1337-49. PMC: 3546380. DOI: 10.1111/j.1939-1676.2012.01026.x. View

17.

Thomas W, Gaber C, JACOBS G, KAPLAN P, Lombard C, Moise N . Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med. 1993; 7(4):247-52. DOI: 10.1111/j.1939-1676.1993.tb01015.x. View

18.

Vollmar A . Echocardiographic measurements in the Irish wolfhound: reference values for the breed. J Am Anim Hosp Assoc. 1999; 35(4):271-7. DOI: 10.5326/15473317-35-4-271. View

19.

Brownlie S, Cobb M . Observations on the development of congestive heart failure in Irish wolfhounds with dilated cardiomyopathy. J Small Anim Pract. 1999; 40(8):371-7. DOI: 10.1111/j.1748-5827.1999.tb03102.x. View

20.

Menaut P, Belanger M, Beauchamp G, Ponzio N, Moise N . Atrial fibrillation in dogs with and without structural or functional cardiac disease: A retrospective study of 109 cases. J Vet Cardiol. 2008; 7(2):75-83. DOI: 10.1016/j.jvc.2005.07.002. View